Advanced search
Publication Cover
Acta Oncologica Volume 46, 2007 - Issue 2
Journal homepage
899
Views
13
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Efficacy of pegylated liposomal doxorubicin in patients with advanced hepatocellular carcinoma

Pehr A. Lind Department of Oncology, Karolinska University Hospital, Huddinge, Stockholm, Sweden; Karolinska Institute, Solna, Sweden
,
Gisela Naucler Department of Oncology, Karolinska University Hospital, Huddinge, Stockholm, Sweden
,
Agneta Holm Department of Oncology, Karolinska University Hospital, Huddinge, Stockholm, Sweden
,
Michael Gubanski Department of Oncology, Karolinska University Hospital, Huddinge, Stockholm, Sweden; Karolinska Institute, Solna, Sweden
&
Christer Svensson Department of Oncology, Karolinska University Hospital, Huddinge, Stockholm, Sweden; Karolinska Institute, Solna, Sweden
Pages 230-233 | Received 06 Dec 2005, Published online: 08 Jul 2009

Citations (13)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Hyun Young Woo, So Young Yoo & Jeong Heo. (2017) New chemical treatment options in second-line hepatocellular carcinoma: what to do when sorafenib fails?. Expert Opinion on Pharmacotherapy 18:1, pages 35-44.
Read now
Antonio Facciorusso, Raffaele Licinio, Brian I Carr, Alfredo Di Leo & Michele Barone. (2015) MEK 1/2 inhibitors in the treatment of hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 9:7, pages 993-1003.
Read now
Ronnie TP Poon & Nicholas Borys. (2009) Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer. Expert Opinion on Pharmacotherapy 10:2, pages 333-343.
Read now

Articles from other publishers (10)

Xinyao Hu, Hua Zhu, Xiaoqin He, Jiayu Chen, Lin Xiong, Yang Shen, Jiayi Li, Yangtao Xu, Wenliang Chen, Xin Liu, Dedong Cao & Ximing Xu. (2023) The application of nanoparticles in immunotherapy for hepatocellular carcinoma. Journal of Controlled Release 355, pages 85-108.
Crossref
Ziqi HouJie LiuZhaoxing JinGuoteng QiuQingyun XieShizheng MiJiwei Huang. (2022) Use of chemotherapy to treat hepatocellular carcinoma. BioScience Trends 16:1, pages 31-45.
Crossref
Lewis Y. Liu, Xue-Zhong Ma, Ben Ouyang, Danielle P. Ings, Sagar Marwah, Jeff Liu, Annie Y. Chen, Rahul Gupta, Justin Manuel, Xu-Chun Chen, Blair K. Gage, Iulia Cirlan, Nicholas Khuu, Sai Chung, Damra Camat, Michael Cheng, Manmeet Sekhon, Kyryl Zagorovsky, Mohamed A. Abdou Mohamed, Cornelia Thoeni, Jawairia Atif, Juan Echeverri, Dagmar Kollmann, Sandra Fischer, Gary D. Bader, Warren C. W. Chan, Tomasz I. Michalak, Ian D. McGilvray & Sonya A. MacParland. (2020) Nanoparticle Uptake in a Spontaneous and Immunocompetent Woodchuck Liver Cancer Model. ACS Nano 14:4, pages 4698-4715.
Crossref
Sibu P. Kuruvilla, Gopinath Tiruchinapally, A. Colleen Crouch, Mohamed E. H. ElSayed & Joan M. Greve. (2017) Dendrimer-doxorubicin conjugates exhibit improved anticancer activity and reduce doxorubicin-induced cardiotoxicity in a murine hepatocellular carcinoma model. PLOS ONE 12:8, pages e0181944.
Crossref
Yannan Dou, Kullervo Hynynen & Christine Allen. (2017) To heat or not to heat: Challenges with clinical translation of thermosensitive liposomes. Journal of Controlled Release 249, pages 63-73.
Crossref
Shaoning Wang, Hui Xu, Jinghua Xu, Ying Zhang, Yingchun Liu, Yi-hui Deng & Dawei Chen. (2010) Sustained Liver Targeting and Improved Antiproliferative Effect of Doxorubicin Liposomes Modified with Galactosylated Lipid and PEG-Lipid. AAPS PharmSciTech 11:2, pages 870-877.
Crossref
Charles H. Cha, M. Wasif Saif, Brett H. Yamane & Sharon M. Weber. (2010) Hepatocellular Carcinoma: Current Management. Current Problems in Surgery 47:1, pages 10-67.
Crossref
Hong-Mook Son & Jun-Shik Choi. (2009) Effects of Morin on the Bioavailability of Doxorubicin for Oral Delivery in Rats. Journal of Korean Pharmaceutical Sciences 39:4, pages 243-248.
Crossref
Yen-Ju Hsieh, Chih-Hsien Chang, Shu-Pei Huang, Chia-Wen Lin, Meng-Nan Wang, Yu-Tse Wu, Yu-Jen Chen & Tung-Hu Tsai. (2008) Effect of cyclosporin A on the brain regional distribution of doxorubicin in rats. International Journal of Pharmaceutics 350:1-2, pages 265-271.
Crossref
M ShehataA MukherjeeR SharmaS Chan. (2016) Liposomal Doxorubicin in Breast Cancer. Women's Health 3:5, pages 557-569.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.